ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,846.20
-0.22%
S&P ASX All Technology
3,076.70
0.66%
Brent Oil
83.52
-0.01%
US Dollar vs AUD
1.49881
0.00%
Bitcoin
70,898.81
-0.79%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Accuray Incorporated (ARAY)

  7. Accuray Incorporated (ARAY) News

ARAY

Accuray (ARAY)

Accuray Incorporated
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ARAY
DateTimeSourceHeadlineSymbolCompany
11/05/202406:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ARAYAccuray Incorporated
09/05/202406:22Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ARAYAccuray Incorporated
02/05/202406:06PR Newswire (US)Accuray Reports Fiscal 2024 Third Quarter Financial ResultsNASDAQ:ARAYAccuray Incorporated
25/04/202421:35PR Newswire (US)Accuray Showcases Advances in Radiation Therapy Solutions Designed to Improve the Cancer Treatment Experience at ESTRO 2024NASDAQ:ARAYAccuray Incorporated
18/04/202421:35PR Newswire (US)Accuray Expands Global Training Center Network With Opening of New Facility in Genolier, SwitzerlandNASDAQ:ARAYAccuray Incorporated
18/04/202406:05PR Newswire (US)Accuray to Report Third Quarter Fiscal 2024 Financial Results on May 1, 2024NASDAQ:ARAYAccuray Incorporated
26/03/202422:35PR Newswire (US)New Data from Two Clinical Studies Indicate High-Risk and Recurrent Prostate Cancers Can be Effectively Treated in 5 Days Using the Accuray CyberKnife® SystemNASDAQ:ARAYAccuray Incorporated
06/03/202408:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARAYAccuray Incorporated
05/03/202408:30PR Newswire (US)Accuray Incorporated to Speak at 36th Annual Roth ConferenceNASDAQ:ARAYAccuray Incorporated
28/02/202409:30PR Newswire (US)Accuray Incorporated to Speak at Oppenheimer 34th Annual Healthcare MedTech & Services ConferenceNASDAQ:ARAYAccuray Incorporated
14/02/202403:19Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ARAYAccuray Incorporated
13/02/202423:35PR Newswire (US)Quebec Cancer Center is First in Canada to Treat Cancer Patients Using the Accuray Radixact® SystemNASDAQ:ARAYAccuray Incorporated
13/02/202407:01Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ARAYAccuray Incorporated
08/02/202408:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ARAYAccuray Incorporated
06/02/202409:30PR Newswire (US)Accuray to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools ConferenceNASDAQ:ARAYAccuray Incorporated
01/02/202408:06PR Newswire (US)Accuray Reports Fiscal 2024 Second Quarter Financial ResultsNASDAQ:ARAYAccuray Incorporated
25/01/202423:35PR Newswire (US)Providence Swedish Radiosurgery Center in Seattle Invests in Second Accuray CyberKnife® System, a Robotic Delivery Device That Makes Extremely Precise Radiation Treatments Possible in 1-5 SessionsNASDAQ:ARAYAccuray Incorporated
17/01/202409:30PR Newswire (US)Accuray to Report Second Quarter Fiscal 2024 Financial Results on January 31, 2024NASDAQ:ARAYAccuray Incorporated
06/01/202408:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARAYAccuray Incorporated
06/01/202408:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARAYAccuray Incorporated
05/12/202323:30PR Newswire (US)Accuray Initiates Sales of the VitalHold™ Solution in Japan, Supporting Surface-guided Radiation Therapy on the Radixact® SystemNASDAQ:ARAYAccuray Incorporated
05/12/202312:51Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARAYAccuray Incorporated
05/12/202312:50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARAYAccuray Incorporated
05/12/202312:50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARAYAccuray Incorporated
05/12/202312:50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARAYAccuray Incorporated
05/12/202312:50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARAYAccuray Incorporated
05/12/202312:50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARAYAccuray Incorporated
05/12/202312:50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARAYAccuray Incorporated
05/12/202312:50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARAYAccuray Incorporated
05/12/202312:50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARAYAccuray Incorporated
 Showing the most relevant articles for your search:NASDAQ:ARAY

Your Recent History

FTSE
UKX
FTSE 100
FX
AUDJPY
AUD vs Yen
ASX
CSL
CSL
ASX
WOW
Woolworths
ASX
XTO
S&P ASX 100
NASDAQ
QQQ
Invesco QQQ Trust Series 1
ASX
CBA
Commonwealth Bank Of Aus...
PM
XAUUSD
Gold vs US Dollar
COIN
ETHUSD
Ethereum
ASX
WES
Wesfarmers
NASDAQ
GOOGL
Alphabet
ASX
AMP
AMP
ASX
ANZ
Australia And New Zealan...
NASDAQ
TSLA
Tesla
NASDAQ
NVDA
NVIDIA
NASDAQ
AMZN
Amazon.com
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved